DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

IPCA Laboratories Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·12 Oct 2026, 9:56 am

IPCA Laboratories

IPCA Laboratories has informed stock exchanges that it has obtained a Certificate under SEBI (Depositories and Participants) Regulations, 2018. This regulatory compliance is a standard requirement for entities that deal with securities depositories and is intended to ensure adherence to the rules governing the dematerialization and settlement of shares.

For investors, this update is largely procedural and does not signal any immediate operational change or business development. It confirms that the company is in compliance with the necessary depository regulations, which is a routine aspect of maintaining a listing on the stock exchange.

Investors should monitor the company's future disclosures for any material news. This current filing is a routine regulatory compliance matter and does not, in itself, indicate any significant shift in the company's financial outlook or market strategy.